Literature DB >> 11685741

Ablative techniques for hepatocellular carcinoma.

C C Barnett1, S A Curley.   

Abstract

The optimal management of hepatocellular carcinoma (HCC) is resection, but this is feasible in only a minority of patients for a variety of reasons, including metastatic disease, major vascular invasion, end-stage liver disease, and poor hepatic reserve. Inoperable patients may be candidates for ablative procedures that may eradicate tumor while minimizing the loss of functioning hepatic tissue that is inevitable with surgical resection. Percutaneous ethanol injection (PEI), hepatic arterial chemoembolization, cryoablation, radiofrequency ablation (RFA), and microwave coagulation offer the potential of local tumor control and sometimes achieve long-term disease-free survival. This review will discuss the indications, anticipated benefits, and limitations of current ablative techniques and place these procedures in proper perspective as options for patients with HCC. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11685741     DOI: 10.1053/sonc.2001.26951

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  7 in total

Review 1.  Treatment of hepatocarcinoma.

Authors:  Beatrice Gerard; Harry Bleiberg
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

2.  Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma.

Authors:  Luigi Solmi; Giovanni Nigro; Enrico Roda
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

3.  Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.

Authors:  Valeria R Mas; Daniel G Maluf; Kellie J Archer; Kenneth Yanek; Xiangrong Kong; Laura Kulik; Chris E Freise; Kim M Olthoff; Rafik M Ghobrial; Paula McIver; Robert Fisher
Journal:  Mol Med       Date:  2008-12-15       Impact factor: 6.354

4.  Model simulation and experimental validation of intratumoral chemotherapy using multiple polymer implants.

Authors:  Brent D Weinberg; Ravi B Patel; Hanping Wu; Elvin Blanco; Carlton C Barnett; Agata A Exner; Gerald M Saidel; Jinming Gao
Journal:  Med Biol Eng Comput       Date:  2008-06-04       Impact factor: 2.602

5.  Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy.

Authors:  Tameyoshi Yamamoto; Hiroaki Nagano; Yasuharu Imai; Kazuto Fukuda; Hitoshi Matsumoto; Motoi Kondo; Hideo Ota; Masato Nakamura; Hiroshi Wada; Takehiro Noda; Bazarragchaa Damdinsuren; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Kenichi Wakasa; Morito Monden
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

Review 6.  Liver-directed therapies for patients with primary liver cancer and hepatic metastases.

Authors:  Cletus A Arciero; Elin R Sigurdson
Journal:  Curr Treat Options Oncol       Date:  2006-09

7.  Experimental Study on Evaluation of Blood Supply Level and Embolization Ratio of Liver Cancer Based on I-Flow Software.

Authors:  Yong Li; Feifan Zhou; Fang Liu; Meng Wang; Wenge Xing
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.